TaskUs, Inc. (TASK) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.87%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.87% | Share-based compensation / revenue. Period ending 2026-06-30. $22.94M ÷ $1.23B × 100 ≈ 1.87% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.23B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 22.94M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 143.54M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.23B | $22.94M | $143.54M | (m) | (m) | 1.87% | (m) | (m) |
| 2026-03-31 | (m) | $1.21B | $27.48M | $140.60M | (m) | (m) | 2.27% | (m) | (m) |
| 2025-12-31 | (m) | $1.18B | $29.66M | $140.63M | (m) | (m) | 2.51% | (m) | (m) |
| 2025-09-30 | (m) | $1.14B | $33.30M | $124.49M | (m) | (m) | 2.91% | (m) | (m) |
| 2025-06-30 | (m) | $1.10B | $37.52M | $110.74M | (m) | (m) | 3.41% | (m) | (m) |
| 2025-03-31 | (m) | $1.05B | $40.34M | $103.10M | (m) | (m) | 3.86% | (m) | (m) |
| 2024-12-31 | (m) | $994.99M | $41.82M | $92.42M | (m) | (m) | 4.20% | (m) | (m) |
| 2024-09-30 | (m) | $955.01M | $42.38M | $102.00M | (m) | (m) | 4.44% | (m) | (m) |
| 2024-06-30 | (m) | $925.29M | $45.61M | $100.75M | (m) | (m) | 4.93% | (m) | (m) |
| 2024-03-31 | (m) | $916.53M | $49.53M | $100.20M | $22.16M | (m) | 5.40% | 4.52× | Reported |
| 2023-12-31 | (m) | $924.37M | $52.76M | $95.04M | $21.72M | (m) | 5.71% | 4.38× | Reported |
| 2023-09-30 | (m) | $932.32M | $56.55M | $86.75M | $20.40M | (m) | 6.07% | 4.25× | Reported |
| 2023-06-30 | (m) | $938.83M | $58.95M | $84.54M | $18.54M | (m) | 6.28% | 4.56× | Reported |
| 2023-03-31 | (m) | $956.12M | $62.84M | $81.74M | $15.42M | (m) | 6.57% | 5.30× | Reported |
| 2022-12-31 | (m) | $960.49M | $68.98M | $83.90M | $11.92M | (m) | 7.18% | 7.04× | Reported |
| 2022-09-30 | (m) | $945.03M | $75.94M | $80.87M | $9.36M | (m) | 8.04% | 8.64× | Reported |
| 2022-06-30 | (m) | $913.95M | $78.96M | $76.27M | $7.13M | (m) | 8.64% | 10.69× | Reported |
| 2022-03-31 | (m) | $847.51M | $65.79M | $-56.13M | $6.53M | (m) | 7.76% | -8.60× | Reported |
| 2021-12-31 | (m) | $760.70M | $46.19M | $-54.28M | $6.50M | (m) | 6.07% | -8.35× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $478.05M | $0.00 | $50.33M | $7.48M | (m) | 0.00% | 6.73× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $359.68M | $0.00 | $36.86M | $9.35M | (m) | 0.00% | 3.94× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.